瑞德西韦和洛匹那韦/利托那韦作为治疗冠状病毒病的潜在药物2019

Journal of Antivirals & Antiretrovirals Pub Date : 2021-01-04 DOI:10.35248/1948-5964.20.S6.002

Reda Bzikha, Bouhmou Ayoub, Bzikha Ilham, S. Bouchnafati

{"title":"瑞德西韦和洛匹那韦/利托那韦作为治疗冠状病毒病的潜在药物2019","authors":"Reda Bzikha, Bouhmou Ayoub, Bzikha Ilham, S. Bouchnafati","doi":"10.35248/1948-5964.20.S6.002","DOIUrl":null,"url":null,"abstract":"Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV aswell as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.","PeriodicalId":15020,"journal":{"name":"Journal of Antivirals & Antiretrovirals","volume":"47 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Corona Virus Disease 2019\",\"authors\":\"Reda Bzikha, Bouhmou Ayoub, Bzikha Ilham, S. Bouchnafati\",\"doi\":\"10.35248/1948-5964.20.S6.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV aswell as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.\",\"PeriodicalId\":15020,\"journal\":{\"name\":\"Journal of Antivirals & Antiretrovirals\",\"volume\":\"47 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Antivirals & Antiretrovirals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/1948-5964.20.S6.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antivirals & Antiretrovirals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/1948-5964.20.S6.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

对SARS-CoV-2有效的药物尚未确定。瑞德西韦和洛匹那韦/利托那韦因其治疗2019冠状病毒病(COVID-19)的潜力而引起了相当大的关注。瑞德西韦不仅在体内，而且在体外测试中都显示出对人类冠状病毒复制的抑制作用，包括SARS-CoV以及洛匹那韦/利托那韦，后者显示出对SARS-CoV-2有希望的抗病毒药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Corona Virus Disease 2019

Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV aswell as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Antivirals & Antiretrovirals

自引率

0.00%

发文量